Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pannuti

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1982
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patientsF Pannuti, C M Camaggi, E Strocchi, et al.
Archivio Per Le Scienze Mediche|October 1, 1982
[Effect of medroxyprogesterone acetate (MAP) in high doses on chlorambucil-induced bone marrow depression. Preliminary results]A Martoni, M Giovannini, E Pollutri, et al.
Minerva Medica|June 8, 1984
[Medical therapy of pain in oncology]F Pannuti, A Cricca, D Marraro, et al.
International Journal of Tissue Reactions|January 1, 1985
Analgesic activity of medroxyprogesterone acetate (MAP) in cancer patients: an antiinflammatory mediated activity?F Pannuti, A Martoni, G Murari, et al.
Drug Intelligence & Clinical Pharmacy|May 1, 1984
Injectable ketoprofen vs. acetylsalicylic acid for the relief of severe cancer pain: a double-blind, crossover trialG Sacchetti, P Camera, A P Rossi, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patientsC M Camaggi, E Strocchi, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over studyC M Camaggi, R Comparsi, E Strocchi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, C Giuliotti, et al.
American Journal of Clinical Oncology|April 25, 2001
Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II studyC Pinto, A Marino, M Guaraldi, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1994
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinomaA Panetta, A Martoni, M Guaraldi, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1982
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patientsF Pannuti, C M Camaggi, E Strocchi, et al.
Archivio Per Le Scienze Mediche|October 1, 1982
[Effect of medroxyprogesterone acetate (MAP) in high doses on chlorambucil-induced bone marrow depression. Preliminary results]A Martoni, M Giovannini, E Pollutri, et al.
Minerva Medica|June 8, 1984
[Medical therapy of pain in oncology]F Pannuti, A Cricca, D Marraro, et al.
International Journal of Tissue Reactions|January 1, 1985
Analgesic activity of medroxyprogesterone acetate (MAP) in cancer patients: an antiinflammatory mediated activity?F Pannuti, A Martoni, G Murari, et al.
Drug Intelligence & Clinical Pharmacy|May 1, 1984
Injectable ketoprofen vs. acetylsalicylic acid for the relief of severe cancer pain: a double-blind, crossover trialG Sacchetti, P Camera, A P Rossi, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patientsC M Camaggi, E Strocchi, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over studyC M Camaggi, R Comparsi, E Strocchi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, C Giuliotti, et al.
American Journal of Clinical Oncology|April 25, 2001
Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II studyC Pinto, A Marino, M Guaraldi, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1994
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinomaA Panetta, A Martoni, M Guaraldi, et al.
Pageof 10